---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-077064"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2025-05-23T23:59:59+00:00"
generated_at: "2026-05-20T13:08:41.124926+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics enters $25M equity purchase agreement with Mast Hill Fund

## Summary
- Mast Hill commits to buy up to $25M of common stock over 24 months at Company's discretion.
- Company issued warrant to Mast Hill for 79,900 shares at $4.00 exercise price, 5-year term.
- Minimum put $5K, max $500K per put or 20% of 5-day avg trading volume.
- Shares subject to 4.99% beneficial ownership cap and Nasdaq 19.99% exchange cap unless stockholder approval.
- Registration rights agreement requires filing registration statement within 60 days.

## SEC filing metadata
- accession: 0000950170-25-077064
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2025-05-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000095017025077064/0000950170-25-077064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000095017025077064/tcrt-20250519.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-077064
- JSON: https://secwatch.observer/filing/0000950170-25-077064.json
- Plain text: https://secwatch.observer/filing/0000950170-25-077064.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.